KLRA Financials

Income Statement
MetricQ2 2026
Revenue
0
Cost of Revenue
0
Gross Profit
0
Operating Expenses
121.4M
R&D
101.1M
SG&A
20.3M
Operating Income
-121373000
EBITDA
-121272000
Net Income
-111307000
EPS (Basic)
$-1.09
EPS (Diluted)
$-1.09
Shares (Diluted)
102.2M
MarketsMoversWatchlist
Kailera Therapeutics (KLRA) — Financials